Whittier Trust CO Of Nevada Inc Ultragenyx Pharmaceutical Inc. Transaction History
Whittier Trust CO Of Nevada Inc
- $3.83 Billion
- Q3 2024
A detailed history of Whittier Trust CO Of Nevada Inc transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Whittier Trust CO Of Nevada Inc holds 70 shares of RARE stock, worth $3,139. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70
Previous 70
-0.0%
Holding current value
$3,139
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RARE
# of Institutions
325Shares Held
85.5MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA9.95MShares$446 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$251 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.12MShares$230 Million0.91% of portfolio
-
Wellington Management Group LLP Boston, MA4.17MShares$187 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$138 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.14B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...